JP2008086352A - Blood processing filter - Google Patents

Blood processing filter Download PDF

Info

Publication number
JP2008086352A
JP2008086352A JP2006267197A JP2006267197A JP2008086352A JP 2008086352 A JP2008086352 A JP 2008086352A JP 2006267197 A JP2006267197 A JP 2006267197A JP 2006267197 A JP2006267197 A JP 2006267197A JP 2008086352 A JP2008086352 A JP 2008086352A
Authority
JP
Japan
Prior art keywords
blood
sheet
filter
filter element
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006267197A
Other languages
Japanese (ja)
Other versions
JP4965212B2 (en
Inventor
Yoshinobu Matsuura
良暢 松浦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Medical Co Ltd
Original Assignee
Asahi Kasei Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Medical Co Ltd filed Critical Asahi Kasei Medical Co Ltd
Priority to JP2006267197A priority Critical patent/JP4965212B2/en
Publication of JP2008086352A publication Critical patent/JP2008086352A/en
Application granted granted Critical
Publication of JP4965212B2 publication Critical patent/JP4965212B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide a flexible blood processing filter in which an exit side container is not in close contact with a filter element to prevent the flow of blood from being blocked and which is excellent in pressure resistance and peeling resistance. <P>SOLUTION: The blood processing filter is composed of: a blood entrance side container on a flexible sheet 8, a blood exit side container 2'; and sheet-like filter elements 3 and 4 for removing microaggregates and leukocytes or the microaggregates, the leukocytes and thrombocytes from the blood. The sheet-like filter elements 3 and 4 are clamped by the respective containers and fixed to the respective containers at the peripheral edge part, and the inside is partitioned into an entrance side space and an exit side space. Between the sheet-like filter elements and the exit side container, a spacer, whose thickness is 0.5 to 5 mm, aperture ratio is 30 to 70% and total area including an aperture part is 10 to 90% by an area ratio to an effective filtration area, is not fixed to any of the filter elements and the respective containers at the peripheral edge part of the sheet-like filter elements. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、血液から凝集物や白血球等の好ましくない成分を除去する為の血液処理フィルターに関する。特に輸血用の全血製剤、赤血球製剤、血小板製剤、血漿製剤などから輸血副作用の原因となる微小凝集物や白血球を除去する目的で用いられる、精密で使い捨ての血液処理フィルターに関するものであって、特に容器の材質として可撓性材料が用いられている血液処理フィルターに関するものである。   The present invention relates to a blood treatment filter for removing undesirable components such as aggregates and leukocytes from blood. In particular, it relates to a precise and disposable blood treatment filter used for the purpose of removing microaggregates and white blood cells that cause transfusion side effects from whole blood preparations for blood transfusion, red blood cell preparations, platelet preparations, plasma preparations, etc. In particular, the present invention relates to a blood processing filter in which a flexible material is used as the material of the container.

ドナーから採血された全血は、赤血球製剤、血小板製剤、血漿製剤等の血液成分製剤に分離され、貯蔵された後に輸血されるのが一般的となりつつある。またこれらの血液製剤に含まれる微小凝集物や白血球が種々の輸血副作用の原因となることから、輸血の前にこれらの好ましくない成分を除去してから輸血する、または、採血後これらの好ましくない成分を除去してから保存した後に輸血に用いる方法が多く用いられている。   It is becoming common for whole blood collected from a donor to be separated into blood component preparations such as erythrocyte preparations, platelet preparations, plasma preparations, etc., stored, and then transfused. In addition, since microaggregates and leukocytes contained in these blood products cause various side effects of blood transfusion, these undesired components are removed before blood transfusion or blood transfusion, or after blood collection, these are undesirable. Many methods are used for blood transfusion after storage after removing the components.

血液製剤から白血球を除去する為の方法としては、血液製剤を白血球除去フィルターで処理するのが最も一般的である。従来、この白血球除去フィルターによる血液製剤の処理は、輸血操作を行う際にベッドサイドで行われることが多かったが、近年では白血球除去製剤の品質管理、及び白血球除去処理の安定性向上の為に、血液センターに於いて保存前に行われることが一般的になりつつある。白血球除去フィルターには、不織布や多孔質体からなるフィルター要素を、採血分離セットのバッグに使用されているものと同一または類似の、可撓性かつ蒸気透過性に優れる素材の容器に充填した、可撓性容器の白血球除去フィルター、および不織布や多孔質体からなるフィルター要素をポリカーボネート等の硬質容器に充填した硬質容器の白血球除去フィルターの二種類が用いられている。   The most common method for removing leukocytes from a blood product is to treat the blood product with a leukocyte removal filter. Conventionally, blood product processing using this leukocyte removal filter has often been performed at the bedside during blood transfusion operations, but in recent years, for the purpose of quality control of leukocyte removal products and improved stability of leukocyte removal processing. It is becoming common for blood centers to be performed before storage. For the leukocyte removal filter, a filter element made of a nonwoven fabric or a porous material is filled in a container made of a material having excellent flexibility and vapor permeability, which is the same as or similar to that used for a bag of a blood collection set. Two types are used: a leukocyte removal filter for a flexible container, and a leukocyte removal filter for a hard container in which a filter element made of a nonwoven fabric or a porous material is filled in a hard container such as polycarbonate.

通常これらの白血球除去フィルターで血液を処理する際は、フィルターの血液入口側に導管を介して接続されている、処理されるべき血液製剤が入ったバッグを、フィルターよりも20cmから100cm程高い位置に置き、重力の作用によって血液製剤をフィルターに通し、フィルターの血液出口側に導管を介して接続された回収バッグに濾過後の血液製剤を収容する。可撓性容器の白血球除去フィルターの場合、濾過の最中にはフィルター要素の抵抗によって圧力損失が生じ、フィルター入口側の空間は陽圧となる。可撓性容器からなるフィルターの場合、容器が可撓性であるが故、この陽圧によって容器は風船状に膨らみ、フィルター要素は出口側の容器に押しつけられる。   Normally, when processing blood with these leukocyte removal filters, the bag containing the blood product to be processed, which is connected to the blood inlet side of the filter via a conduit, is positioned 20 to 100 cm higher than the filter. The blood product is passed through the filter by the action of gravity, and the filtered blood product is stored in a collection bag connected to the blood outlet side of the filter via a conduit. In the case of the leukocyte removal filter of the flexible container, a pressure loss occurs due to the resistance of the filter element during the filtration, and the space on the filter inlet side becomes a positive pressure. In the case of a filter made of a flexible container, since the container is flexible, this positive pressure causes the container to expand in a balloon shape, and the filter element is pressed against the container on the outlet side.

一方、出口側容器とフィルター要素との空隙は、出口に接続された導管内の血液が重力によって流下して、通常フィルターよりも50〜100cm低い位置に置かれた濾過後の血液を収納するためのバッグへと移動しようとするため、この作用によって逆に陰圧となり、可撓性容器はフィルター要素に密着し、更に血液出口の開口部がふさがれた状態となる。即ち、血液はフィルター内から流出しようとするが、開口部が閉塞されているため、血液が流れ出すことが困難となる。   On the other hand, the gap between the outlet side container and the filter element is for storing blood after filtration, which is placed at a position 50 to 100 cm lower than the normal filter, as blood in the conduit connected to the outlet flows down by gravity. In this case, the negative pressure is reversed by this action, the flexible container is in close contact with the filter element, and the opening of the blood outlet is blocked. That is, blood tries to flow out of the filter, but it is difficult for blood to flow out because the opening is closed.

この問題を解決する方法として、先行技術には、フィルター要素と出口側容器との間に連接棒と呼ばれる軟質塩ビチューブを挿入して密着を防ぐ方法(特許文献1)や、軟質容器内面に高低差0.2〜2mmの凹凸をつけて密着を防ぐ方法(特許文献2)、ニットファイバー製のスクリーン等を挿入する方法(特許文献3)、メッシュまたは突起状物等を配置する方法(特許文献4)等が提案されている。
しかしながら、特許文献1に記載されている連接棒を挿入する方法では、フィルター要素と出口側容器との間の空間を保つために多くの連接棒を必要とし、そのために製造工程が複雑になり、またコストが増すことになる。特許文献3、特許文献4に記載されるように、スクリーン、メッシュまたは突起状物を挿入する方法では、コストが増すだけでなく、スクリーンやメッシュのような太い繊維を可撓性容器に溶着しようとする場合、通常の溶着では十分に繊維を押し潰すことができないためリークなどの問題が生じ、逆に通常より強い条件で溶着すると可撓性容器の強度が低下してしまう。また、突起状物を用いる場合では、別部材を挿入することによる容器の溶着不良を起こす危険性がある。特許文献2に開示された方法は、連接棒やスクリーン、メッシュまたは突起状物を挿入する方法の問題点を解決する方法として提案されたものの、凹凸部を持つ容器の均一な溶着は難しく、安定した強度が得難い。
As a method for solving this problem, the prior art includes a method of preventing adhesion by inserting a soft PVC tube called a connecting rod between the filter element and the outlet side container (Patent Document 1), A method for preventing adhesion by providing unevenness with a difference of 0.2 to 2 mm (Patent Document 2), a method for inserting a knit fiber screen or the like (Patent Document 3), a method for arranging a mesh or a protrusion (Patent Document) 4) etc. are proposed.
However, in the method of inserting the connecting rod described in Patent Document 1, a large number of connecting rods are required to maintain the space between the filter element and the outlet side container, which complicates the manufacturing process. In addition, the cost increases. As described in Patent Document 3 and Patent Document 4, the method of inserting a screen, mesh or protrusions not only increases the cost, but also welds thick fibers such as a screen and mesh to a flexible container. In such a case, the fibers cannot be sufficiently crushed by ordinary welding, which causes problems such as leakage. Conversely, when welding is performed under conditions stronger than usual, the strength of the flexible container is lowered. Moreover, when using a protrusion-like thing, there exists a danger of causing the welding defect of a container by inserting another member. Although the method disclosed in Patent Document 2 was proposed as a method for solving the problem of the method of inserting a connecting rod, a screen, a mesh, or a protrusion, uniform welding of a container having an uneven portion is difficult and stable. It is difficult to obtain the strength.

血液の流れが阻害されるのを防ぐとともに、耐圧性、耐剥離性に優れた可撓性の血液処理フィルターとして、第一、第二のフィルター要素と出口側容器との間に厚み1cmに換算した時の通気度が3〜40cc/cm/秒で、厚みが0.04〜0.25cmである第三のフィルター要素が配置されている血液処理フィルターが提案されている(特許文献5)。この血液処理フィルターは従来のものに比べ、濾過時の圧力や遠心操作時のストレスに対しても十分な強度を有しており、かつ濾過時間の短縮効果も見られているが、それでも第三のフィルター要素中を濾過面に対して平行方向へ流れる時の通液抵抗が高く血液の流れが阻害されるため、必ずしも十分な効果が得られていない。また、50〜5000μmの孔径を有する多孔質体もしくは不織布を配置したフィルター(特許文献6)についても、同様の理由で十分な効果が得られていない。
欧州特許出願公開第0526678号明細書 特開平11−216179号公報 特開平7−267871号公報 国際公開第95/17236号パンフレット 特開2003−180822号公報 国際公開第02/04045号パンフレット
As a flexible blood treatment filter that prevents blood flow from being blocked and has excellent pressure resistance and peel resistance, it is converted to a thickness of 1 cm between the first and second filter elements and the outlet side container. A blood treatment filter in which a third filter element having an air permeability of 3 to 40 cc / cm 2 / sec and a thickness of 0.04 to 0.25 cm is arranged has been proposed (Patent Document 5). . Compared to conventional filters, this blood treatment filter has sufficient strength against pressure during filtration and stress during centrifugation, and is effective in shortening filtration time. Since the fluid flow resistance is high when flowing through the filter element in the direction parallel to the filtration surface, the blood flow is inhibited, so that a sufficient effect is not necessarily obtained. Moreover, sufficient effect is not acquired for the same reason also about the filter (patent document 6) which has arrange | positioned the porous body which has the hole diameter of 50-5000 micrometers, or a nonwoven fabric.
European Patent Application No. 0526678 JP-A-11-216179 JP-A-7-267871 WO95 / 17236 pamphlet JP 2003-180822 A International Publication No. 02/04045 Pamphlet

本発明の課題は、濾過時に生ずる入口側の陽圧によってシート状フィルター要素が出口側容器に押しつけられ、および/または出口側の陰圧によって出口側容器がシート状フィルター要素に張り付くことにより、出口側容器がシート状フィルター要素に密着することを防止した血液処理用フィルターを提供することである。より具体的には、上記の作用を有することにより、血液の流れが阻害される恐れのない、即ち血液の流れが均一で血液処理速度の速い可撓性の血液処理フィルターを提供するとともに、耐圧性、耐剥離性に優れ、濾過時の圧力や遠心操作時のストレスに対しても十分な強度を持つ可撓性の血液処理フィルターを提供することにある。   The problem of the present invention is that the sheet-like filter element is pressed against the outlet-side container by the positive pressure on the inlet side generated during filtration and / or the outlet-side container sticks to the sheet-like filter element by the negative pressure on the outlet side. It is an object of the present invention to provide a blood processing filter in which a side container is prevented from sticking to a sheet-like filter element. More specifically, by having the above-described action, the blood flow is not hindered, that is, the blood flow is uniform and the blood treatment speed is flexible and the blood treatment speed is high. It is an object of the present invention to provide a flexible blood treatment filter that is excellent in properties and peel resistance and has sufficient strength against pressure during filtration and stress during centrifugation.

さらにはスクイージング操作やポンプによる急速濾過で発生する更に高い圧力にも耐えて、リークや破裂や剥離を生じない可撓性の血液処理フィルターを提供することにある。   It is another object of the present invention to provide a flexible blood processing filter that can withstand higher pressures generated by squeezing operation or rapid filtration by a pump and does not cause leakage, rupture, or peeling.

本発明者らは上記の課題を解決するために鋭意研究した結果、例えば出口側容器とシート状フィルター要素との間であって、有効濾過面の中央部に切り欠きを設けたシート状のスペーサを配置することにより、血液が流れる時の通液抵抗が下がり、出口側が陰圧であってもスペーサによって血液の通る空間が保持され、かつ血液の流れは阻害されないことを見出した。その結果、血液が濾材を均一に流れ、濾過時間が大幅に短縮されるだけではなく、濾材が有効に使用されるため濾過効率が飛躍的に向上することを見出し、さらに別の部材を溶着することによる容器の溶着不良を起こすことがなく、耐圧性、耐剥離性の面において格段に優れた強度を持つ血液処理フィルターが得られることを見出し、本発明を得るに至った。   As a result of diligent research to solve the above problems, the present inventors have, for example, a sheet-like spacer provided between the outlet-side container and the sheet-like filter element and provided with a notch at the center of the effective filtration surface. It has been found that the flow resistance when blood flows decreases, the space through which the blood passes is maintained by the spacer even when the outlet side is under negative pressure, and the blood flow is not hindered. As a result, blood not only flows uniformly through the filter medium, and the filtration time is greatly shortened, but also the filter medium is effectively used, so that the filtration efficiency is dramatically improved and another member is welded. It has been found that a blood treatment filter having a remarkably excellent strength in terms of pressure resistance and peeling resistance can be obtained without causing poor welding of the container.

すなわち、本発明は以下を含む。
(1)可撓性シートに血液入口が取付けられた入口側容器と、可撓性シートに血液出口が取付けられた出口側容器と、血液から微小凝集物と白血球または微小凝集物と白血球と血小板を除去するためのシート状フィルター要素とからなり、シート状フィルター要素が前記夫々の容器で挟み込まれ、その周縁部にて前記夫々の容器に固定されることにより、内部が入口側空間と出口側空間とに仕切られてなる血液処理用フィルターにおいて、シート状フィルター要素と出口側容器との間に、厚みが0.5〜5mm、開孔率30〜70%、開孔部を含む総面積が有効濾過面積に対する面積比で10〜90%のスペーサが配置され、該スペーサはシート状フィルター要素の周縁部にてフィルター要素および前記夫々の容器のいずれにも固定されていないことを特徴とする血液処理フィルター。
(2)スペーサが、有効濾過面の重心を中心に有効濾過面形状を1/16収縮した面を覆っている(1)の血液処理フィルター。
(3)スペーサの周辺部の一部と出口側可撓性容器とがフィルター要素の固定部以外で接合されている(1)または(2)の血液処理フィルター。
(4)スペーサの材質が可撓性容器の材質と同じである(1)乃至(3)の何れかの血液処理フィルター。
That is, the present invention includes the following.
(1) An inlet side container in which a blood inlet is attached to a flexible sheet, an outlet side container in which a blood outlet is attached to a flexible sheet, and microaggregates and leukocytes or microaggregates and leukocytes and platelets from blood. The sheet-like filter element is sandwiched between the respective containers and fixed to the respective containers at the peripheral edge thereof, so that the inside is the inlet side space and the outlet side. In the blood processing filter that is partitioned into a space, between the sheet-like filter element and the outlet side container, the thickness is 0.5 to 5 mm, the porosity is 30 to 70%, and the total area including the aperture is A spacer having an area ratio of 10 to 90% with respect to the effective filtration area is arranged, and the spacer is fixed to both the filter element and the respective containers at the peripheral edge of the sheet-like filter element. Blood treating filter, characterized that no.
(2) The blood processing filter according to (1), wherein the spacer covers a surface obtained by shrinking the effective filtration surface shape by 1/16 about the center of gravity of the effective filtration surface.
(3) The blood processing filter according to (1) or (2), wherein a part of the periphery of the spacer and the outlet-side flexible container are joined at a portion other than the fixed portion of the filter element.
(4) The blood processing filter according to any one of (1) to (3), wherein a material of the spacer is the same as that of the flexible container.

本発明の血液処理フィルターは、濾過時に生ずる入口側の陽圧および/または出口側の陰圧によってシート状フィルター要素が出口側容器に押しつけられたり、出口側容器がシート状フィルター要素に張り付つけられても、出口側容器がシート状フィルター要素に密着することなく、血液の流れが阻害される恐れのない可撓性の血液処理フィルターとなった。   In the blood treatment filter of the present invention, the sheet-like filter element is pressed against the outlet-side container by the positive pressure on the inlet side and / or the negative pressure on the outlet side generated during filtration, or the outlet-side container is stuck to the sheet-like filter element. In this case, the outlet side container is not in close contact with the sheet-like filter element, so that a flexible blood processing filter is obtained in which the blood flow is not hindered.

また、耐圧性、耐剥離性に優れ、濾過時の圧力や遠心操作時のストレスに対しても十分な強度を持つ可撓性の血液処理フィルターとなった。さらにはスクイージング操作やポンプによる急速濾過で発生する更に高い圧力にも耐えて、リークや破裂や剥離を生じない可撓性の血液処理フィルターとなった。   In addition, it is a flexible blood treatment filter that is excellent in pressure resistance and peel resistance and has sufficient strength against pressure during filtration and stress during centrifugation. Furthermore, it was able to withstand even higher pressures generated by squeezing operation and rapid filtration with a pump, resulting in a flexible blood treatment filter that does not leak, rupture or peel off.

以下に本発明について詳細に説明する。
本発明の血液処理フィルターの全体的形状は、平板状であり、その平面が矩形状、円盤状、長円板状などのいずれでも良いが、フィルター製造時の材料ロスを少なくするためには、矩形状が好ましい。なお、正方形や菱形も矩形状の一種と見なすこととする。
The present invention is described in detail below.
The overall shape of the blood treatment filter of the present invention is a flat plate shape, and the plane may be any of a rectangular shape, a disk shape, an oblong plate shape, etc., but in order to reduce material loss during filter production, A rectangular shape is preferred. Squares and rhombuses are also considered as a kind of rectangular shape.

本発明に用いる可撓性容器は、可撓性の合成樹脂製のシート状成形物から形成されるのが好ましく、さらに熱可塑性樹脂であることが好ましい。シート状であることが必要なのは、フィルター要素と可撓性容器、或いは可撓性容器どうしの接着の際、厚みが均一なシート状であることが必要なためであり、接着部が均一の厚みであれば、シートまたはフィルム、更には射出成形品から可撓性容器が作られていてもシート状成形物から形成されているとみなすことができる。   The flexible container used in the present invention is preferably formed from a sheet-like molded product made of a flexible synthetic resin, and more preferably a thermoplastic resin. The sheet shape is required because the filter element and the flexible container or the flexible container need to have a uniform sheet thickness, and the bonded portion has a uniform thickness. If so, even if a flexible container is made from a sheet or film, or an injection-molded product, it can be regarded as being formed from a sheet-like molded product.

本発明の可撓性容器には、シート、フィルムとして市販されている材料であれば使用することができる。例えば、軟質ポリ塩化ビニル、ポリウレタン、エチレン−酢酸ビニル共重合体、ポリエチレン及びポリプロピレンのようなポリオレフィン、スチレン−ブタジエン−スチレン共重合体の水添物、スチレン−イソプレン−スチレン共重合体またはその水添物等の熱可塑性エラストマー、及び、熱可塑性エラストマーとポリオレフィン、エチレン−エチルアクリレート等の軟化剤との混合物等が好適な材料として挙げられる。血液と接触するので、可撓性容器の材質は、好ましくは血液バック等の医療品の材料として用いられている、軟質塩化ビニル、ポリオレフィン、及び、これらを主成分とする熱可塑性エラストマーであり、更に好ましくは軟質塩化ビニルである。   Any material commercially available as a sheet or film can be used in the flexible container of the present invention. For example, soft polyvinyl chloride, polyurethane, ethylene-vinyl acetate copolymer, polyolefin such as polyethylene and polypropylene, hydrogenated styrene-butadiene-styrene copolymer, styrene-isoprene-styrene copolymer or hydrogenated product thereof Suitable materials include thermoplastic elastomers such as products, and mixtures of thermoplastic elastomers and softeners such as polyolefin and ethylene-ethyl acrylate. Since it comes into contact with blood, the material of the flexible container is preferably soft vinyl chloride, polyolefin, and thermoplastic elastomers containing these as the main components, which are used as materials for medical products such as blood bags, More preferred is soft vinyl chloride.

本発明のシート状フィルター要素は、血液から微小凝集物と白血球、または微小凝集物と白血球と血小板を除去するためのものであり、不織布や織布などの繊維状多孔性媒体や、スポンジ状構造物などの三次元網目状連続細孔を有する多孔質体などの公知の濾過媒体を用いることができる。メッシュやスクリーンなど、シート状フィルター要素と可撓性容器との空間を作るものは、溶着性に優れないので該当しない。これらフィルター要素の素材としては、例えば、ポリプロピレン、ポリエチレン、スチレン−イソブチレン−スチレン共重合体、ポリウレタン、ポリエステル、等が挙げられる。フィルター要素が不織布である場合には、生産性の点から特に好ましい。   The sheet-like filter element of the present invention is for removing microaggregates and leukocytes, or microaggregates, leukocytes and platelets from blood, and is a fibrous porous medium such as nonwoven fabric or woven fabric, or a sponge-like structure. A known filtration medium such as a porous body having three-dimensional network-like continuous pores such as an object can be used. Those which create a space between the sheet-like filter element and the flexible container, such as a mesh and a screen, are not applicable because they have poor weldability. Examples of the material for these filter elements include polypropylene, polyethylene, styrene-isobutylene-styrene copolymer, polyurethane, polyester, and the like. When the filter element is a nonwoven fabric, it is particularly preferable from the viewpoint of productivity.

本発明で用いられるシート状フィルター要素は、単一のシート状フィルター要素でもよく、複数のシート状フィルター要素からなってもよい。複数のシート状フィルター要素からなる場合、上流に配置された微小凝集物を除去する第一のシート状フィルター要素と、第一のシート状フィルター要素の下流に配置された白血球または白血球と血小板を除去するための第二のシート状フィルター要素からなるのが好ましい。例えば、入口側に繊維径が数〜数十μmの不織布からなるシート状フィルター要素を凝集物除去の為の第一のシート状フィルター要素として配置し、次に、繊維径が0.3〜3.0μmの不織布からなるシート状フィルター要素を、白血球または白血球と血小板を除去するための第二のシート状フィルター要素として配置し、更に下流側に特定の空間を有するポストフィルターを積層して用いる場合もある。   The sheet filter element used in the present invention may be a single sheet filter element or a plurality of sheet filter elements. In the case of a plurality of sheet-like filter elements, a first sheet-like filter element that removes microaggregates arranged upstream, and leukocytes or leukocytes and platelets arranged downstream of the first sheet-like filter element are removed. Preferably, it comprises a second sheet-like filter element. For example, a sheet-like filter element made of a nonwoven fabric having a fiber diameter of several to several tens of μm is disposed on the inlet side as a first sheet-like filter element for removing aggregates, and then the fiber diameter is 0.3 to 3 When a sheet filter element made of 0.0 μm non-woven fabric is arranged as a second sheet filter element for removing leukocytes or leukocytes and platelets, and a post filter having a specific space on the downstream side is laminated and used. There is also.

第一、第二のシート状フィルター要素は、それぞれが更に複数種類のシート状フィルター要素から構成されていても良く、片方のみが複数種類のシート状フィルター要素から構成されてもよい。例えば、繊維径が30〜40μmの不織布および/または繊維径が10〜20μmの不織布からなる第一のフィルター要素を上流側に配置し、第一のシート状フィルター要素の下流側に繊維径が1.5〜2.5μmの不織布および/または繊維径が0.5〜1.8μmの不織布からなる第二のシート状フィルター要素を配置して用いても良い。また、太い繊維径の不織布と細い繊維径の不織布が交互に配置されていても良いが、太い繊維径の不織布が上流側に配置されている方が好ましい。   Each of the first and second sheet-like filter elements may further be constituted by a plurality of types of sheet-like filter elements, or only one of them may be constituted by a plurality of types of sheet-like filter elements. For example, a first filter element made of a nonwoven fabric having a fiber diameter of 30 to 40 μm and / or a nonwoven fabric having a fiber diameter of 10 to 20 μm is arranged on the upstream side, and the fiber diameter is 1 on the downstream side of the first sheet-like filter element. You may arrange | position and use the 2nd sheet-like filter element which consists of a nonwoven fabric of 5-2.5 micrometers, and / or a nonwoven fabric whose fiber diameter is 0.5-1.8 micrometers. Moreover, although the nonwoven fabric of a thick fiber diameter and the nonwoven fabric of a thin fiber diameter may be arrange | positioned alternately, it is preferable that the nonwoven fabric of a thick fiber diameter is arrange | positioned upstream.

以下、本発明のフィルターの詳細な構造について、図面を参照しながら説明する。
図2は本発明の血液処理フィルターの一例を示す全体図である。図2に示すように、本発明においては、可撓性容器のうち、ろ過される血液を導入する側の容器を入口側容器2、ろ過された血液が導出される側の容器を出口側容器2’と称する。これらは互いに対称的な構造または同一構造であるのが一般的であるが、それに限定される必要はない。
入口側容器2には、容器の外部から内部へ液体を漏れなく流通させる血液入口1が、また出口側容器2’には、容器の内部から外部へ液体を漏れなく流通させる血液出口5が取付けられている。このような容器構造は、予め開口部を一箇所設けた容器用の可撓性シートを作成し、その容器開口部に、別途成型した血液入口1(血液出口5)を接着または溶着して液密に取付けることにより得られる。血液入口1と血液出口5のうち少なくとも血液出口5は、後述する入口側容器2、出口側容器2’およびシート状フィルター要素3,4とが固定された周縁部よりも内側に設けられている場合に、本発明においてより効果的である。血液入口1(血液出口5)の外側開口部1a(5a)と内側開口部1b(5b)は、図6のAのように互いに対面するものや、図6のBおよび図2のように互いに対面せず、外側開口部1a(5a)がシート状フィルター要素のシート面に対して略垂直になる形状でもよい。
Hereinafter, the detailed structure of the filter of the present invention will be described with reference to the drawings.
FIG. 2 is an overall view showing an example of the blood processing filter of the present invention. As shown in FIG. 2, in the present invention, among the flexible containers, the container on the side for introducing the blood to be filtered is the inlet side container 2, and the container on the side from which the filtered blood is led out is the outlet side container. 2 ′. These are generally symmetrical structures or the same structure, but need not be limited thereto.
The inlet side container 2 is provided with a blood inlet 1 through which liquid flows from the outside to the inside of the container without leakage, and the outlet side container 2 ′ is attached with blood outlet 5 through which liquid flows from the inside of the container to the outside without leakage. It has been. In such a container structure, a flexible sheet for a container in which one opening is provided in advance is prepared, and a separately formed blood inlet 1 (blood outlet 5) is bonded or welded to the container opening. Obtained by dense installation. At least the blood outlet 5 of the blood inlet 1 and the blood outlet 5 is provided on the inner side of the peripheral portion to which the inlet side container 2, the outlet side container 2 ′ and the sheet-like filter elements 3 and 4 described later are fixed. In some cases, it is more effective in the present invention. The outer opening 1a (5a) and the inner opening 1b (5b) of the blood inlet 1 (blood outlet 5) face each other as shown in FIG. 6A, and each other as shown in FIG. 6B and FIG. The outer opening 1a (5a) may be shaped so as to be substantially perpendicular to the sheet surface of the sheet-like filter element without facing each other.

本発明の血液処理用フィルターは、シート状フィルター要素が前記夫々の容器で挟み込まれ、その周縁部にて前記夫々の容器に固定されることにより、内部が入口側空間と出口側空間とに仕切られている。この固定は溶着によって行われる。   In the blood processing filter of the present invention, the sheet-like filter element is sandwiched between the respective containers and fixed to the respective containers at the peripheral edge thereof, thereby dividing the interior into an inlet side space and an outlet side space. It has been. This fixing is performed by welding.

本発明の可撓性容器とシート状フィルター要素の溶着形態は、例えば可撓性容器を直接シート状フィルター要素とポストフィルターに溶着させる容器溶着型、フィルター要素を一旦シート状の可撓性フレームに溶着した後に、該フレームを可撓性容器と溶着するフレーム溶着型などいずれの形態でもよい。製造工程が少なく、また原材料のロスが少ない点で容器溶着型が好ましい。   The welding form of the flexible container and the sheet-like filter element of the present invention is, for example, a container welding type in which the flexible container is directly welded to the sheet-like filter element and the post filter, and the filter element is once formed into a sheet-like flexible frame. After the welding, any form such as a frame welding type in which the frame is welded to a flexible container may be used. The container welding type is preferable in that the number of manufacturing steps is small and the loss of raw materials is small.

図1および2は、容器溶着型のフィルター作製過程を示す図である。血液入口1が設けられた入口側容器2と、血液出口5が設けられた出口側容器2’とで第一、第二のシート状フィルター要素3,4を挟み込み(図1を参照)、その周縁部を二重に溶着することにより、容器溶着型血液処理フィルター装置を得ることができる。なお、二重に溶着するとは、シート状フィルター要素と入口側(出口側)容器とを溶着した第1シール区域6と、入口側容器と出口側容器とを直接溶着した第2シール区域7とを形成することをいう。
また、図3および4は、フレーム溶着型のフィルター作製過程を示す図である。第一、第二のシート状フィルター要素3,4をフレーム状可撓性シート8で挟み込んでフレーム部を溶着した後、これを、血液入口1が設けられた入口側容器2と、血液出口5が設けられた出口側容器2’とで挟み込み(図3を参照)、その周縁部で入口側容器2、フレーム状可撓性シート8および出口側容器2’を溶着することにより(図4を参照)、フレーム溶着型血液処理フィルター装置を得ることができる。
1 and 2 are views showing a process for producing a container welding type filter. The first and second sheet-like filter elements 3 and 4 are sandwiched between the inlet-side container 2 provided with the blood inlet 1 and the outlet-side container 2 ′ provided with the blood outlet 5 (see FIG. 1), A container-welded blood treatment filter device can be obtained by double-welding the peripheral edge. The double welding means that the first seal area 6 where the sheet-like filter element and the inlet side (outlet side) container are welded, and the second seal area 7 where the inlet side container and the outlet side container are directly welded, To form.
3 and 4 are diagrams showing a process for producing a frame welding type filter. After the first and second sheet-like filter elements 3 and 4 are sandwiched between the frame-like flexible sheet 8 and the frame portion is welded, this is connected to the inlet-side container 2 provided with the blood inlet 1 and the blood outlet 5. (See FIG. 3), and the inlet side container 2, the frame-shaped flexible sheet 8 and the outlet side container 2 ′ are welded at the peripheral edge (see FIG. 4). See), a frame-welded blood treatment filter device can be obtained.

本発明の可撓性容器またはフレーム状可撓性シートとシート状フィルター要素との溶着は、高周波溶着、超音波溶着による内部溶着、ヒートシールによる外部溶着などの方法で行うことが出来るが、均一な溶着性という点で高周波溶着が好ましい。溶着を行う場合は、シート状フィルター要素の最外層、つまり可撓性シートと接するシート状フィルター要素の空隙部に溶融した可撓性シート材が入り込み、冷却後、各繊維をアンカーの如くした溶着面が形成されることが重要である。そのために、最外層のフィルター要素の繊維径を大きくすることで孔径(空隙)を大きくすることが好ましい。   The flexible container or the frame-like flexible sheet of the present invention and the sheet-like filter element can be welded by a method such as high-frequency welding, internal welding by ultrasonic welding, or external welding by heat sealing. High frequency welding is preferable in terms of excellent weldability. When welding is performed, the melted flexible sheet material enters the outermost layer of the sheet-like filter element, that is, the gap of the sheet-like filter element in contact with the flexible sheet, and after cooling, each fiber is welded like an anchor. It is important that the surface be formed. Therefore, it is preferable to increase the pore diameter (void) by increasing the fiber diameter of the outermost filter element.

また、最外層のシート状フィルター要素の融点は、可撓性シート材料の融点より高いことが望ましい。これは、可撓性シート材料とシート状フィルター要素に接着性がない場合でも、可撓性シート材が溶融して最外層のフィルター要素の中に入り込み、内層部のシート状フィルター要素が最外層のフィルター要素と接着することにより、可撓性シート材料とシート状フィルター要素との接着部が高い強度を得ることができるためである。可撓性シート材料とシート状フィルター要素に接着性がある材料どうしの組合せの場合、繊維径、孔径、及び融点はこのようになっている必要はない。   The melting point of the outermost sheet-like filter element is preferably higher than the melting point of the flexible sheet material. This is because even when the flexible sheet material and the sheet-like filter element are not adhesive, the flexible sheet material melts and enters the outermost filter element, and the inner-layer sheet-like filter element is the outermost layer. This is because the adhesive portion between the flexible sheet material and the sheet-like filter element can obtain high strength by adhering to the filter element. In the case of the combination of the flexible sheet material and the material having adhesiveness to the sheet-like filter element, the fiber diameter, the hole diameter, and the melting point need not be such.

本発明のスペーサとは、厚みが0.5〜5mm、開孔率30〜70%、開孔部を含む総面積が有効濾過面積に対する面積比で10〜90%の開孔を持つシート状成形物のことを言う。
本発明において、スペーサの厚さは0.5〜5mmである事が必要である。これは、厚さが0.5mm未満の場合、血液の流れる空間が小さいのでスペーサとしての機能を殆ど発揮できず、流速向上の効果が小さくなる。反対に5mmを越える場合、濾過終了後に血液処理用フィルター内部に血液が残ってしまい、血液の回収量の低下が発生する。また、溶着時に、可撓性容器の溶着部を高周波溶着等で溶融させたときスペーサの厚さが厚い場合、溶着部が引張られるため、溶着部脇の厚さが薄くなる。スペーサの厚みが薄い場合溶着部脇が薄くなることを防げるため、リーク等が発生することを防ぐことができ、製品使用時に発生するフィルター内圧によるリーク等の発生を防ぐことができる。好ましくは1〜3mmである。
The spacer of the present invention is a sheet-like molding having a thickness of 0.5 to 5 mm, a hole area ratio of 30 to 70%, and a total area including the hole part of 10 to 90% in terms of the area ratio to the effective filtration area. Say things.
In the present invention, the spacer needs to have a thickness of 0.5 to 5 mm. When the thickness is less than 0.5 mm, the space through which the blood flows is small, so that the function as a spacer can hardly be exhibited, and the effect of improving the flow rate becomes small. On the other hand, if it exceeds 5 mm, blood remains inside the blood processing filter after the filtration is completed, and the amount of collected blood is reduced. Further, when the welded portion of the flexible container is melted by high frequency welding or the like at the time of welding, if the spacer is thick, the welded portion is pulled, so the thickness of the side of the welded portion is reduced. When the spacer is thin, it is possible to prevent the side of the welded portion from becoming thin, so that it is possible to prevent the occurrence of leaks and the like, and it is possible to prevent the occurrence of leaks due to the filter internal pressure that occurs during product use. Preferably it is 1-3 mm.

本発明において、スペーサの開孔率は、(スペーサの開孔部の面積/スペーサの開孔部を含む面積)×100で定義される。この開孔率が大きいほど、スペーサとシート状フィルター要素、及びスペーサと入口側容器または出口側容器との接触が少なくなり、シート状フィルター要素と可撓性容器の間を流体が流れるときの抵抗が小さくなることにより、流体の流れ性が向上する。そのため30%以上の開効率が必要となる。但し、開孔率が大きくなりすぎると、工業的に取り扱う場合にハンドリングが困難となるため開効は70%以下である必要がある。つまり、スペーサの開効率は30〜70%である必要がある。より好ましくは30〜60%、更に好ましくは30〜50%であれば更に高い効果を発揮することができる。   In the present invention, the aperture ratio of the spacer is defined by (area of the aperture of the spacer / area including the aperture of the spacer) × 100. The larger the hole area ratio, the smaller the contact between the spacer and the sheet-like filter element and between the spacer and the inlet-side container or the outlet-side container, and the resistance when fluid flows between the sheet-like filter element and the flexible container. By reducing, the fluidity of the fluid is improved. Therefore, an opening efficiency of 30% or more is required. However, if the hole area ratio is too high, handling becomes difficult when handled industrially, so the opening effect needs to be 70% or less. That is, the opening efficiency of the spacer needs to be 30 to 70%. More preferably 30 to 60%, still more preferably 30 to 50%, even higher effects can be exhibited.

本発明において、スペーサの開孔部を含む面積がフィルター要素の有効濾過面積に対し10%以上のスペーサを配置すれば、入口側容器もしくは出口側容器とシート状フィルター要素、または、可撓性フレームとシート状フィルター要素の溶着時に、溶融、固化し、収縮したために発生するシート状フィルター要素のしわを減少させることができる。また、出口側容器とシート状フィルター要素との間の流れに対して抵抗を減少させることが可能となる結果、高い流速を得ることが可能となる。   In the present invention, if a spacer having an area including the opening portion of the spacer is 10% or more with respect to the effective filtration area of the filter element, the inlet side container or the outlet side container and the sheet-like filter element, or the flexible frame In addition, when the sheet-like filter element is welded, wrinkles of the sheet-like filter element that are generated due to melting, solidification, and contraction can be reduced. Moreover, it becomes possible to reduce a resistance with respect to the flow between an outlet side container and a sheet-like filter element, As a result, it becomes possible to obtain a high flow velocity.

一方、スペーサの開孔部を含む面積がフィルター要素の有効濾過面積に対し90%以下のスペーサを配置すれば、高周波溶着等の方法を用いてシート状フィルター周縁部を固定する際、スペーサと固定部に十分な距離を確保できるため、スペーサが固定部に挟まれることなく容器の耐圧性や剥離性を低下させることが無い。従って、スペーサの開孔部を含む面積はフィルター要素の有効濾過面積に対し10〜90%である必要があり、より好ましくは20〜85%、更に好ましくは30〜80%であれば更に高い効果を発揮することができる。   On the other hand, if a spacer with an area including the opening portion of the spacer of 90% or less with respect to the effective filtration area of the filter element is arranged, the spacer is fixed when fixing the peripheral edge of the sheet-like filter using a method such as high frequency welding. Since a sufficient distance can be secured in the part, the pressure resistance and peelability of the container are not lowered without the spacer being sandwiched between the fixed parts. Therefore, the area including the opening portion of the spacer needs to be 10 to 90% with respect to the effective filtration area of the filter element, more preferably 20 to 85%, and still more preferably 30 to 80%. Can be demonstrated.

スペーサを配置する際、その周囲が可撓性容器とシート状フィルター要素、または、可撓性フレームとシート状フィルター要素との溶着部より5mm以上離れていることが好ましい。溶着時に、溶着部にシート材料が挟まれることを確実に防ぐことが可能になるためである。溶着部が直線でない場合は、平行な線と仮定して5mm以上離れていれば問題はない。この大きさであれば、溶着時にスペーサの厚みにより影響を受け、可撓性容器の溶着部脇の厚さが薄くなりリーク等が発生することを防ぐことができ、製品使用時に発生するフィルター内圧によるリーク等の発生を防ぐことができる。   When the spacer is disposed, it is preferable that the periphery thereof be separated from the welded portion between the flexible container and the sheet-like filter element or the flexible frame and the sheet-like filter element by 5 mm or more. This is because it is possible to reliably prevent the sheet material from being sandwiched between the welded portions at the time of welding. In the case where the welded portion is not a straight line, there is no problem as long as the welded portion is separated by 5 mm or more assuming a parallel line. This size is affected by the spacer thickness at the time of welding, and the thickness of the side of the welded portion of the flexible container can be reduced to prevent leaks. It is possible to prevent the occurrence of leaks and the like.

ここで、図6を用いて血液処理フィルター内の血液の流れを説明する。図6において矢印が示すように、血液流入口から流入した血液は、シート状フィルター要素の抵抗が高いことと、シート状フィルター要素を通過するよりも血液流入口から流入する血液量の方が多いことにより、先ずは入口側容器との隙間を満たす。続いて、血液がシート状フィルター要素を通過し始め、今度は濾過された血液がシート状フィルター要素と出口側容器との隙間を満たしつつ血液流出口から流出する。これをシート状フィルター要素の平面側から見れば、血液流入口から流入した血液は、流入口直下から放射状にシート状フィルター要素表面を覆い、一方、反対面では濾過された血液がシート状フィルター要素表面から反放射状に血液流出口へ流れていく。   Here, the flow of blood in the blood processing filter will be described with reference to FIG. As shown by the arrows in FIG. 6, the blood flowing in from the blood inlet has a higher resistance of the sheet-like filter element, and the amount of blood flowing from the blood inlet is larger than passing through the sheet-like filter element. Thus, first, the gap with the inlet side container is filled. Subsequently, blood begins to pass through the sheet-like filter element, and this time, the filtered blood flows out from the blood outlet while filling the gap between the sheet-like filter element and the outlet side container. If this is seen from the plane side of the sheet-like filter element, the blood flowing in from the blood inlet covers the surface of the sheet-like filter element radially from directly under the inlet, while the filtered blood is on the opposite side of the sheet-like filter element. It flows from the surface to the blood outlet in an anti-radial manner.

また、血液処理フィルターにおいては、フィルター内部の血液の流れをより効率的にするため、血液流入口と流出口がシート状フィルター要素の面に正対称にはならず、互いに離間する形状が一般的である。   Also, in blood treatment filters, in order to make the blood flow inside the filter more efficient, the blood inlet and outlet are generally not symmetrical with respect to the surface of the sheet-like filter element, and are generally separated from each other. It is.

以上を考慮すると、シート状フィルター要素の表面では、血液流入口方向から流出口方向への血液の流れが生じやすいため、スペーサはこの血流方向に沿った縦リブが配置されている(血流方向に沿った開口部を有する)ことが流れ性の点から好ましい。例えば、図6に示す矩形フィルターの場合は、図7に示すように長手方向に縦リブが設けられた形状が好ましい。また、図示しないが、血液流入口と血液流出口とがシート状フィルター要素の中央で正対称になる場合には、スペーサは中央から放射状にリブが伸展した形状が好ましい。   Considering the above, since the flow of blood from the blood inlet direction to the outlet direction is likely to occur on the surface of the sheet-like filter element, the spacer is provided with longitudinal ribs along this blood flow direction (blood flow). It is preferable from the viewpoint of flowability to have an opening along the direction). For example, in the case of the rectangular filter shown in FIG. 6, a shape in which vertical ribs are provided in the longitudinal direction as shown in FIG. 7 is preferable. Although not shown, when the blood inlet and the blood outlet are symmetric in the center of the sheet-like filter element, the spacer preferably has a shape in which ribs extend radially from the center.

スペーサのリブについては横リブ、すなわち、図7の矩形における短方向のリブを設けてあっても好ましい。横リブを設けるのは、リブ全体が一体化された方が、工業的に取り扱う上でハンドリングが容易となるからである。さらに横リブは、縦リブと直交する必要はなく縦リブをつなげるように配置されていれば良い。縦リブ、横リブともに、直線である必要はなく曲線になっていても問題はない。   Regarding the rib of the spacer, it is preferable to provide a lateral rib, that is, a short rib in the rectangle of FIG. The reason why the horizontal ribs are provided is that handling is easier when the entire ribs are integrated for industrial handling. Further, the horizontal ribs do not need to be orthogonal to the vertical ribs, and may be arranged so as to connect the vertical ribs. Both the vertical ribs and the horizontal ribs need not be straight, and there is no problem even if they are curved.

縦リブの間隔は1〜7mmである事が好ましい。より好ましくは2〜5mmである。これは、縦リブ同士の間隔が1mm未満の場合、血液の流れる空間が小さく流速向上の効果が小さくなる傾向にあるためである。反対に、間隔が7mmを越える場合には、血液処理用フィルターの出口側空間の陰圧が大きくなった際、出口側容器とシート状フィルター要素との接触面積が著しく増大し、スペーサとしての機能を殆ど発揮できなくなる。その結果、流速向上の効果が小さくなる傾向にあり、血液の回収量の低下も発生し易くなる。   The interval between the vertical ribs is preferably 1 to 7 mm. More preferably, it is 2-5 mm. This is because when the interval between the longitudinal ribs is less than 1 mm, the space through which blood flows is small and the effect of improving the flow velocity tends to be small. On the contrary, when the interval exceeds 7 mm, when the negative pressure in the outlet side space of the blood processing filter increases, the contact area between the outlet side container and the sheet-like filter element increases remarkably and functions as a spacer. Can hardly be exhibited. As a result, the effect of improving the flow rate tends to be small, and a reduction in the amount of collected blood tends to occur.

一方、縦リブの幅は1〜10mmであることが好ましい。縦リブの幅が1mm未満の場合、シート状フィルター要素と可撓性容器との間に挟まれた場合に縦リブが変形しやすく、シート状フィルター要素と可撓性容器との隙間を保てなくなる恐れがある。反対に、幅が10mmを越える場合、大きいほどスペーサとシート状フィルター要素、及びスペーサと可撓性容器との接触が大きく、流体の流れの抵抗となる。より好ましくは1〜7mm、更に好ましくは1〜5mmであれば更に高い効果を発揮することができる。   On the other hand, the width of the vertical rib is preferably 1 to 10 mm. When the width of the longitudinal rib is less than 1 mm, the longitudinal rib is easily deformed when sandwiched between the sheet-like filter element and the flexible container, and the gap between the sheet-like filter element and the flexible container is maintained. There is a risk of disappearing. On the contrary, when the width exceeds 10 mm, the larger the contact, the greater the contact between the spacer and the sheet-like filter element, and the spacer and the flexible container, resulting in resistance to fluid flow. More preferably 1 to 7 mm, and even more preferably 1 to 5 mm, a higher effect can be exhibited.

本発明のスペーサは、必ずしもシート状フィルター要素の有効濾過面積の中心に配置する必要はない。ただし、可撓性容器とシート状フィルター要素、または、可撓性フレームとシート状フィルター要素との溶着時に、溶融、固化、収縮の過程でシート状フィルター要素にしわが発生することがあり、そのしわは、有効濾過面に対しての重心を中心に有効濾過面形状を1/16収縮した面が大きい場所となる。例えば、矩形状の場合、対角線に沿ってしわが発生するため、対角線の交点付近が最も凹凸の大きい場所となり、それは重心を中心に有効濾過面形状を1/16収縮した面付近となる。従って、その部分にスペーサを入れることにより、シート状フィルター要素と出口側容器との間の流れ抵抗を減少させることができるため、高い流速を得ることが可能となるため好ましい。更に好ましくは1/9以上を覆うと、高い流速を得ることができる。   The spacer of the present invention is not necessarily arranged at the center of the effective filtration area of the sheet-like filter element. However, when the flexible container and the sheet-like filter element or the flexible frame and the sheet-like filter element are welded, wrinkles may occur in the sheet-like filter element in the process of melting, solidifying, and shrinking. Is a place where the surface obtained by shrinking the effective filter surface shape by 1/16 around the center of gravity with respect to the effective filter surface is large. For example, in the case of a rectangular shape, wrinkles are generated along the diagonal line, so that the vicinity of the intersection of the diagonal line is the place with the largest unevenness, which is the vicinity of the surface obtained by shrinking the effective filtration surface shape about 1/16 around the center of gravity. Therefore, it is preferable to insert a spacer in that portion because the flow resistance between the sheet-like filter element and the outlet side container can be reduced, and a high flow rate can be obtained. More preferably, when 1/9 or more is covered, a high flow rate can be obtained.

スペーサは、その周辺部の一部で、シート状フィルター要素の固定部以外の出口側容器の内側に接合されていることが好ましい。そうすることにより、シート状フィルター要素と可撓性容器、可撓性容器と可撓性シート状フレームとを溶着する際に、スペーサの位置がずれて、スペーサを挟んだまま溶着してしまうことを回避できる。また、流体のろ過中に、濾材のしわの部分からずれることで、効果が低下することを防ぐことができる。接合の方法としては、高周波溶着、超音波溶着、ヒートシール等の材料どうしを溶融させ貼り付ける方法、接着剤を用いて貼り付ける方法等を用いることができるが、安全性の観点から、他の物質を使用しない、溶融しての貼り付けが好ましい。   It is preferable that the spacer is joined to the inside of the outlet side container other than the fixing portion of the sheet-like filter element at a part of the peripheral portion thereof. By doing so, when the sheet-like filter element and the flexible container and the flexible container and the flexible sheet-like frame are welded, the position of the spacer is shifted, and the spacer is welded with the spacer interposed therebetween. Can be avoided. Moreover, it can prevent that an effect falls by shifting | deviating from the wrinkle part of a filter medium during filtration of a fluid. As a bonding method, high frequency welding, ultrasonic welding, a method of melting and pasting materials such as heat seal, a method of pasting using an adhesive, and the like can be used. It is preferable to use a paste without melting the substance.

スペーサの材質が可撓性容器の材質と同じ場合、スペーサの周辺部の一部を出口側容器に固定する際に接着性が優れるため、加工性がよく好ましい。   When the material of the spacer is the same as the material of the flexible container, the workability is good because the adhesiveness is excellent when a part of the periphery of the spacer is fixed to the outlet side container.

[実施例]
以下、実施例に基づき、本発明の血液処理フィルターについて詳細に説明するが、本発明はこれらによって限定されるものではない。
[Example]
Hereinafter, although the blood processing filter of this invention is demonstrated in detail based on an Example, this invention is not limited by these.

(1)血液処理フィルターの流れ性試験の方法
本発明の血液処理フィルターを、貯留バッグと回収バッグとの間に配置し、貯留バッグに接続した入口側導管を血液処理フィルターの血液入口へ、回収バッグに接続した出口側導管を血液処理フィルターの血液出口へそれぞれ接続した。また、それぞれの導管として、内径3mm、外径4.2mmの塩化ビニル製のチューブを使用し、入口側導管の長さを35cm、出口側導管の長さを85cmとした。入口側導管をクランプで閉じた後、注射用蒸留水(大塚製薬株式会社製)にポリビニルピロリドン(以下、PVPと言うことがある。和光純薬工業株式会社製)を添加し、粘度を10.0mPa・Sに調製したPVP水溶液460gを貯留バッグへ入れた。
(1) Blood processing filter flowability test method The blood processing filter of the present invention is disposed between a storage bag and a recovery bag, and the inlet side conduit connected to the storage bag is recovered to the blood inlet of the blood processing filter. The outlet side conduit connected to the bag was connected to the blood outlet of the blood treatment filter. Further, as each conduit, a tube made of vinyl chloride having an inner diameter of 3 mm and an outer diameter of 4.2 mm was used, and the length of the inlet side conduit was set to 35 cm and the length of the outlet side conduit was set to 85 cm. After closing the inlet-side conduit with a clamp, polyvinylpyrrolidone (hereinafter sometimes referred to as “PVP”, manufactured by Wako Pure Chemical Industries, Ltd.) is added to distilled water for injection (manufactured by Otsuka Pharmaceutical Co., Ltd.). 460 g of the PVP aqueous solution prepared at 0 mPa · S was put in a storage bag.

システム全体を吊り下げ、また、回収バッグを天秤の上に静置した後、入口側導管を閉じているクランプを開放し、濾過を開始した。クランプを開放した時間からPVP溶液が回収バッグに到達するまでの時間をプライミング時間とした。
さらに、PVP溶液が回収バッグに到達してから貯留バッグのPVP溶液が空になるまでの時間を処理時間とした。貯留バッグが空になった後、1分毎に回収バッグを載せた天秤の値の読み取り、1分間の天秤の値の変動が0.5g以下になった時点で回収を終了し、貯留バッグが空になってから回収が終了するまでの時間を回収時間、回収終了時の天秤の値を回収量とした。
The entire system was suspended and the collection bag was allowed to stand on the balance, and then the clamp closing the inlet side conduit was opened and filtration was started. The time from when the clamp was released until the PVP solution reached the collection bag was defined as the priming time.
Furthermore, the time from when the PVP solution reached the collection bag until the PVP solution in the storage bag became empty was defined as the processing time. After the storage bag is emptied, reading the value of the balance on which the collection bag is placed every minute. When the fluctuation of the value of the balance for 1 minute becomes 0.5 g or less, the collection is terminated. The time from emptying to the end of recovery was taken as the recovery time, and the value of the balance at the end of the recovery was taken as the recovered amount.

(2)血液処理用フィルターのリーク検査方法
血液処理用フィルター装置に一定圧力をかけ、リークの発生の有無を確認する方法である。血液出口は、片止めした軟質ポリ塩化ビニル製チューブを接着し密封した。血液入口に圧気ラインを接続した導管を接続する。その後、フィルター装置を水温25℃の水中に沈め、フィルター装置を水中に沈めたままの状態で、導管から30kPaの空気を注入し、フィルター装置の第1シール区域から空気が漏れるか、確認を行う。10個検査し、その発生率をリーク発生率とする。
(2) Leakage inspection method for blood processing filter This is a method of applying a certain pressure to the blood processing filter device to confirm the occurrence of leakage. The blood outlet was sealed by adhering a single piece of soft polyvinyl chloride tube. Connect a conduit with a pressure line to the blood inlet. Thereafter, the filter device is submerged in water at a temperature of 25 ° C., and 30 kPa of air is injected from the conduit while the filter device is submerged in water, and it is confirmed whether air leaks from the first seal area of the filter device. . Ten pieces are inspected, and the occurrence rate is defined as the leak occurrence rate.

繊維径12μm、目付30g/m、厚さ0.189mmのポリエステル不織布である第一のフィルター要素、繊維径1.2μm、目付40g/m、厚さ0.235mmのポリエステル不織布である第二のフィルター要素を、それぞれ第一のフィルター要素を血液の入口側、出口側にそれぞれ4枚で、第二のフィルター要素を25枚重ねたものを挟みフィルター要素とした。
血液入口の付いた塩化ビニル樹脂製シートからなる入口側可撓性容器、シート状フィルター要素、厚さ1.2mm、寸法45mm×65mmの塩化ビニル樹脂製シートの中央に寸法4mm×55mmの開口部6個を開口部の間隔(縦リブの幅)2mmで配置したスペーサ、血液出口の付いた塩化ビニル樹脂製シートからなる出口側可撓性容器、をこの順序に配置した。このように、シート状フィルター要素とスペーサを入口側可撓性容器と出口側可撓性容器で挟んだ状態で、スペーサを有効ろ過面の中央に配置し、フィルター要素がスペーサを挟み込まないで可撓性容器と一体化するように溶着し、有効濾過部の平面寸法が65mm×85mmの容器溶着型血液処理フィルター装置を作成した。
流れ性試験を行ない、プライミング時間、処理時間、回収時間、回収量を測定した。開効率、開口部を含む総面積が有効濾過面積に対する面積比、リーク発生率および結果を表1に示す。
A first filter element which is a polyester nonwoven fabric having a fiber diameter of 12 μm, a basis weight of 30 g / m 2 and a thickness of 0.189 mm, a second filter element which is a polyester nonwoven fabric having a fiber diameter of 1.2 μm, a basis weight of 40 g / m 2 and a thickness of 0.235 mm. Each of the filter elements was composed of four first filter elements on the blood inlet side and outlet side, and 25 layers of the second filter elements sandwiched between them.
An inlet side flexible container made of a vinyl chloride resin sheet with a blood inlet, a sheet-like filter element, an opening having a size of 4 mm × 55 mm at the center of a vinyl chloride resin sheet having a thickness of 1.2 mm and a size of 45 mm × 65 mm Six spacers arranged at intervals of openings (width of vertical ribs) of 2 mm and outlet-side flexible containers made of vinyl chloride resin sheets with blood outlets were arranged in this order. In this way, with the sheet-like filter element and the spacer sandwiched between the inlet side flexible container and the outlet side flexible container, the spacer is arranged in the center of the effective filtration surface, so that the filter element does not sandwich the spacer. The container was welded so as to be integrated with the flexible container, and a container-welded blood treatment filter device having an effective filtration part with a plane size of 65 mm × 85 mm was prepared.
A flowability test was performed, and priming time, processing time, recovery time, and recovery amount were measured. Table 1 shows the open efficiency, the ratio of the total area including the opening to the effective filtration area, the leak rate, and the results.

厚さ0.8mm、寸法45mm×65mmの塩化ビニル樹脂製シートの中央に、寸法4mm×55mmの開口部6個を開口部の間隔(縦リブの幅)2mmで配置したスペーサを用いた以外は実施例1と同じ方法でフィルターを作成し、流れ性試験を行ない、プライミング時間、処理時間、回収時間、回収量を測定した。開効率、開口部を含む総面積が有効濾過面積に対する面積比、リーク発生率および結果を表1に示す。   Except for using a spacer in which six openings of dimensions 4 mm x 55 mm are arranged at intervals of the openings (width of vertical ribs) of 2 mm at the center of a vinyl chloride resin sheet of thickness 0.8 mm and dimensions 45 mm x 65 mm A filter was prepared by the same method as in Example 1, a flowability test was performed, and priming time, processing time, recovery time, and recovery amount were measured. Table 1 shows the open efficiency, the ratio of the total area including the opening to the effective filtration area, the leak rate, and the results.

厚さ1.2mm、寸法30mm×30mmの塩化ビニル樹脂製シートの中央に、寸法3.75mm×25mmの開口部4個を開口部の間隔(縦リブの幅)3mmで配置したスペーサを用いた以外は実施例1と同じ方法でフィルターを作成し、プライミング時間、処理時間、回収時間、回収量を測定した。開効率、開口部を含む総面積が有効濾過面積に対する面積比、リーク発生率および結果を表1に示す。   In the center of a vinyl chloride resin sheet having a thickness of 1.2 mm and dimensions of 30 mm × 30 mm, a spacer was used in which four openings with dimensions of 3.75 mm × 25 mm were arranged at intervals of openings (width of vertical ribs) of 3 mm. Except for the above, a filter was prepared in the same manner as in Example 1, and the priming time, processing time, recovery time, and recovery amount were measured. Table 1 shows the open efficiency, the ratio of the total area including the opening to the effective filtration area, the leak rate, and the results.

厚さ2.7mm、寸法45mm×65mmの塩化ビニル樹脂製シートの中央に、寸法4mm×55mmの開口部6個を開口部の間隔(縦リブの幅)2mmで配置したスペーサを用いた以外は実施例1と同じ方法でフィルターを作成し、流れ性試験を行ない、プライミング時間、処理時間、回収時間、回収量を測定した。開効率、開口部を含む総面積が有効濾過面積に対する面積比、リーク発生率および結果を表1に示す。   Except for using a spacer in which six openings of dimensions 4 mm x 55 mm are arranged in the center of a vinyl chloride resin sheet having a thickness of 2.7 mm and dimensions of 45 mm x 65 mm with an interval of the openings (width of vertical ribs) of 2 mm. A filter was prepared by the same method as in Example 1, a flowability test was performed, and priming time, processing time, recovery time, and recovery amount were measured. Table 1 shows the open efficiency, the ratio of the total area including the opening to the effective filtration area, the leak rate, and the results.

厚さ1.2mm、寸法45mm×65mmの塩化ビニル樹脂製シートの中央に、寸法4mm×7mmの開口部36個を横方向に6個、縦方向に6個、横方向の開口部の間隔(縦リブの幅)2mm、縦方向の開孔部の間隔(横リブの幅)1.4mmで配置したスペーサを用いた以外は実施例1と同じ方法でフィルターを作成し、流れ性試験を行ない、プライミング時間、処理時間、回収時間、回収量を測定した。開効率、開口部を含む総面積が有効濾過面積に対する面積比、リーク発生率および結果を表1に示す。   In the center of a vinyl chloride resin sheet having a thickness of 1.2 mm and dimensions of 45 mm × 65 mm, there are six openings of 4 mm × 7 mm in the horizontal direction, six in the vertical direction, and intervals between the openings in the horizontal direction ( A filter was prepared in the same manner as in Example 1 except that spacers arranged with a width of the vertical ribs of 2 mm and an interval between the vertical opening portions (the width of the horizontal ribs) of 1.4 mm, and the flowability test was performed. Priming time, processing time, recovery time, and recovery amount were measured. Table 1 shows the open efficiency, the ratio of the total area including the opening to the effective filtration area, the leak rate, and the results.

厚さ1.2mm、寸法55mm×75mmの塩化ビニル樹脂製シートの中央に、寸法6.5mm×71mmの開口部7個を開口部の間隔(縦リブの幅)1mmで配置したスペーサを用いた以外は実施例1と同じ方法でフィルターを作成し、流れ性試験を行ない、プライミング時間、処理時間、回収時間、回収量を測定した。開効率、開口部を含む総面積が有効濾過面積に対する面積比、リーク発生率および結果を表1に示す。   In the center of a vinyl chloride resin sheet having a thickness of 1.2 mm and a size of 55 mm × 75 mm, a spacer in which seven openings of a size of 6.5 mm × 71 mm are arranged with an interval of the openings (width of the vertical rib) of 1 mm was used. Except for the above, a filter was prepared in the same manner as in Example 1, a flowability test was performed, and priming time, processing time, recovery time, and recovery amount were measured. Table 1 shows the open efficiency, the ratio of the total area including the opening to the effective filtration area, the leak rate, and the results.

[比較例1]
スペーサを配置しなかったこと以外は実施例1と同じ方法でフィルターを作成し、プライミング時間、処理時間、回収時間、回収量を測定した。開効率、開口部を含む総面積が有効濾過面積に対する面積比、リーク発生率および結果を表2に示す。
[Comparative Example 1]
A filter was prepared in the same manner as in Example 1 except that no spacer was arranged, and priming time, processing time, recovery time, and recovery amount were measured. Table 2 shows the open efficiency, the ratio of the total area including the opening to the effective filtration area, the leak occurrence rate, and the results.

[比較例2]
厚さ7mm、寸法45mm×65mmの塩化ビニル樹脂製シートの中央に、寸法4mm×55mmの開口部6個を開口部の間隔(縦リブの幅)2mmで配置したスペーサを用いた以外は実施例1と同じ方法でフィルターを作成し、プライミング時間、処理時間、回収時間、回収量を測定した。開効率、開口部を含む総面積が有効濾過面積に対する面積比、リーク発生率および結果を表2に示す。
[Comparative Example 2]
Example except for using a spacer in which six openings of dimensions 4 mm x 55 mm are arranged at intervals of the openings (width of vertical ribs) of 2 mm in the center of a sheet of vinyl chloride resin of thickness 7 mm and dimensions 45 mm x 65 mm A filter was prepared by the same method as in Example 1, and the priming time, processing time, recovery time, and recovery amount were measured. Table 2 shows the open efficiency, the ratio of the total area including the opening to the effective filtration area, the leak occurrence rate, and the results.

表1の結果から、スペーサを挿入しない場合(比較例1)は、処理時間、回収時間ともに長く操作上の問題が懸念された。また、スペーサの厚さが必要以上に大きい場合(比較例2)は、通常の操作でフィルター要素と容器の周縁部を溶着する際に可撓性容器の溶着部脇の厚さが薄くなりリークの発生が見られたため、不良品の発生が懸念された。
これらに対して、スペーサが特定の大きさ,配置の場合には、いずれもそれらの欠点が解消された。
From the results of Table 1, when the spacer was not inserted (Comparative Example 1), both the processing time and the recovery time were long and there was a concern about operational problems. Further, when the spacer thickness is larger than necessary (Comparative Example 2), the thickness of the flexible container side becomes thin when the filter element and the peripheral edge of the container are welded by a normal operation. There was concern about the occurrence of defective products.
On the other hand, in the case where the spacer has a specific size and arrangement, those disadvantages are solved.

本発明血液処理フィルターは、輸血治療の現場で、主に輸血用の血液から微小凝集物と白血球、または微小凝集物と白血球と血小板を除去するためのフィルターとして有用であり、また本発明血液処理フィルターは体外循環白血球除去療法に用いられるフィルターとしても有用である。   The blood treatment filter of the present invention is useful as a filter for removing microaggregates and leukocytes or microaggregates, leukocytes and platelets from blood for transfusion mainly at the site of blood transfusion treatment. The filter is also useful as a filter used for extracorporeal circulating leukocyte removal therapy.

容器溶着型の血液処理用フィルターを作製する前の、各部品が積層された断面模式図。The cross-sectional schematic diagram in which each component was laminated | stacked before producing the container welding type blood processing filter. 図1の積層物を溶着して作製された、本発明の血液処理用フィルター装置の例を示す断面模式図。The cross-sectional schematic diagram which shows the example of the filter apparatus for blood processing of this invention produced by welding the laminated body of FIG. フレーム溶着型の血液処理用フィルターを作製する前の、各部品が積層された断面模式図。The cross-sectional schematic diagram in which each component was laminated | stacked before producing the flame welding type filter for blood processing. 図3の積層物を溶着して作製された、本発明の血液処理用フィルター装置の例を示す断面模式図。The cross-sectional schematic diagram which shows the example of the filter apparatus for blood processing of this invention produced by welding the laminated body of FIG. 図4をさらに別仕様の、可撓性容器を用いたときの例を示す断面図。Sectional drawing which shows the example when the flexible container of another specification of FIG. 4 is used. 血液処理フィルター内の血液の流れを示す模式図Schematic diagram showing the flow of blood in the blood treatment filter 本発明のスペーサの形状の例Example of spacer shape of the present invention

符号の説明Explanation of symbols

1:血液の入口
2:可撓性容器
3:第一のフィルター要素
4:第二のフィルター要素
5:血液の出口
6:第1シール区域
7:第2シール区域
8:可撓性フレーム
1: Blood inlet 2: Flexible container 3: First filter element 4: Second filter element 5: Blood outlet 6: First seal area 7: Second seal area 8: Flexible frame

Claims (4)

可撓性シートに血液入口が取付けられた入口側容器と、
可撓性シートに血液出口が取付けられた出口側容器と、
血液から微小凝集物と白血球または微小凝集物と白血球と血小板を除去するためのシート状フィルター要素とからなり、
シート状フィルター要素が前記夫々の容器で挟み込まれ、その周縁部にて前記夫々の容器に固定されることにより、内部が入口側空間と出口側空間とに仕切られてなる血液処理用フィルターにおいて、
シート状フィルター要素と出口側容器との間に、厚みが0.5〜5mm、開孔率30〜70%、開孔部を含む総面積が有効濾過面積に対する面積比で10〜90%のスペーサが配置され、該スペーサはシート状フィルター要素の周縁部にてフィルター要素および前記夫々の容器のいずれにも固定されていないことを特徴とする血液処理フィルター。
An inlet side container having a blood inlet attached to a flexible sheet;
An outlet side container having a blood outlet attached to a flexible sheet;
It consists of a sheet-like filter element for removing microaggregates and leukocytes or microaggregates and leukocytes and platelets from blood,
In the blood processing filter in which the sheet-like filter element is sandwiched between the respective containers and is fixed to the respective containers at the periphery thereof, whereby the inside is partitioned into the inlet side space and the outlet side space.
A spacer having a thickness of 0.5 to 5 mm, a hole area ratio of 30 to 70%, and a total area including the hole area of 10 to 90% in terms of the effective filtration area between the sheet-like filter element and the outlet side container. The blood processing filter is characterized in that the spacer is not fixed to either the filter element or the respective containers at the peripheral edge of the sheet-like filter element.
スペーサが、有効濾過面の重心を中心に有効濾過面形状を1/16収縮した面を覆っている請求項1記載の血液処理フィルター。   The blood processing filter according to claim 1, wherein the spacer covers a surface obtained by shrinking the effective filtration surface shape by 1/16 about the center of gravity of the effective filtration surface. スペーサの周辺部の一部と出口側可撓性容器とがフィルター要素の固定部以外で接合されている請求項1または2記載の血液処理フィルター。   The blood processing filter according to claim 1 or 2, wherein a part of the peripheral portion of the spacer and the outlet side flexible container are joined at a portion other than the fixing portion of the filter element. スペーサの材質が可撓性容器の材質と同じである請求項1乃至3の何れかに記載の血液処理フィルター。   The blood processing filter according to any one of claims 1 to 3, wherein a material of the spacer is the same as that of the flexible container.
JP2006267197A 2006-09-29 2006-09-29 Blood treatment filter Expired - Fee Related JP4965212B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006267197A JP4965212B2 (en) 2006-09-29 2006-09-29 Blood treatment filter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006267197A JP4965212B2 (en) 2006-09-29 2006-09-29 Blood treatment filter

Publications (2)

Publication Number Publication Date
JP2008086352A true JP2008086352A (en) 2008-04-17
JP4965212B2 JP4965212B2 (en) 2012-07-04

Family

ID=39371150

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006267197A Expired - Fee Related JP4965212B2 (en) 2006-09-29 2006-09-29 Blood treatment filter

Country Status (1)

Country Link
JP (1) JP4965212B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011072814A (en) * 2010-04-09 2011-04-14 Asahi Kasei Medical Co Ltd Blood processing filter
US20120067810A1 (en) * 2010-09-21 2012-03-22 Asahi Kasei Medical Co., Ltd. Blood processing filter and the method for manufacturing the same
WO2012039402A1 (en) * 2010-09-21 2012-03-29 旭化成メディカル株式会社 Blood treatment filter and method for manufacturing blood treatment filter
WO2015050216A1 (en) * 2013-10-02 2015-04-09 旭化成メディカル株式会社 Blood processing filter and blood processing method
CN109224534A (en) * 2018-09-07 2019-01-18 深圳市普特生物医学工程有限公司 Blood component separator

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5388670A (en) * 1977-01-17 1978-08-04 Asahi Chem Ind Co Ltd Fluid treating apparatus
JPH04212373A (en) * 1990-06-25 1992-08-03 Terumo Corp Filter for capturing white blood cell and production thereof
JP2003180822A (en) * 2001-10-11 2003-07-02 Kawasumi Lab Inc Blood component separator

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5388670A (en) * 1977-01-17 1978-08-04 Asahi Chem Ind Co Ltd Fluid treating apparatus
JPH04212373A (en) * 1990-06-25 1992-08-03 Terumo Corp Filter for capturing white blood cell and production thereof
JP2003180822A (en) * 2001-10-11 2003-07-02 Kawasumi Lab Inc Blood component separator

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011072814A (en) * 2010-04-09 2011-04-14 Asahi Kasei Medical Co Ltd Blood processing filter
JP5524340B2 (en) * 2010-09-21 2014-06-18 旭化成メディカル株式会社 Blood processing filter and method for manufacturing blood processing filter
JPWO2012039402A1 (en) * 2010-09-21 2014-02-03 旭化成メディカル株式会社 Blood processing filter and method for manufacturing blood processing filter
JP2014131751A (en) * 2010-09-21 2014-07-17 Asahi Kasei Medical Co Ltd Blood processing filter, and manufacturing method for blood processing filter
EP2620169A1 (en) * 2010-09-21 2013-07-31 Asahi Kasei Medical Co., Ltd. Blood processing filter and method for producing blood processing filter
US8851296B2 (en) 2010-09-21 2014-10-07 Asahi Kasei Medical Co., Ltd. Blood processing filter and the method for manufacturing the same
JPWO2012039400A1 (en) * 2010-09-21 2014-02-03 旭化成メディカル株式会社 Blood processing filter and method for manufacturing blood processing filter
JP5487315B2 (en) * 2010-09-21 2014-05-07 旭化成メディカル株式会社 Blood processing filter and method for manufacturing blood processing filter
US8881914B2 (en) 2010-09-21 2014-11-11 Asahi Kasei Medical Co., Ltd. Blood processing filter and the method for manufacturing the same
WO2012039400A1 (en) * 2010-09-21 2012-03-29 旭化成メディカル株式会社 Blood processing filter and method for producing blood processing filter
WO2012039402A1 (en) * 2010-09-21 2012-03-29 旭化成メディカル株式会社 Blood treatment filter and method for manufacturing blood treatment filter
US20120067810A1 (en) * 2010-09-21 2012-03-22 Asahi Kasei Medical Co., Ltd. Blood processing filter and the method for manufacturing the same
EP2620169A4 (en) * 2010-09-21 2015-02-11 Asahi Kasei Medical Co Ltd Blood processing filter and method for producing blood processing filter
US9421320B2 (en) 2010-09-21 2016-08-23 Asahi Kasei Medical Co., Ltd. Blood processing filter and the method for manufacturing the same
WO2015050216A1 (en) * 2013-10-02 2015-04-09 旭化成メディカル株式会社 Blood processing filter and blood processing method
JPWO2015050216A1 (en) * 2013-10-02 2017-03-09 旭化成メディカル株式会社 Blood processing filter and blood processing method
US10188782B2 (en) 2013-10-02 2019-01-29 Asahi Kasei Medical Co., Ltd. Blood processing filter and blood processing method
CN109224534A (en) * 2018-09-07 2019-01-18 深圳市普特生物医学工程有限公司 Blood component separator

Also Published As

Publication number Publication date
JP4965212B2 (en) 2012-07-04

Similar Documents

Publication Publication Date Title
JP4917076B2 (en) Blood treatment filter
KR101518687B1 (en) Blood processing filter and method for producing blood processing filter
JP5487315B2 (en) Blood processing filter and method for manufacturing blood processing filter
JP5680675B2 (en) Blood processing filter and method for priming blood processing filter
JP5840602B2 (en) Blood treatment filter
JP5806815B2 (en) Blood treatment filter and blood filtration method
JP4965212B2 (en) Blood treatment filter
JP5631731B2 (en) Blood treatment filter
JP4916831B2 (en) Blood processing filter and blood processing method
JP2008086353A5 (en)
JP4986285B2 (en) Filtration method and apparatus for blood or blood components using leukocyte removal filter
JP4144707B2 (en) Blood treatment filter
JP4130401B2 (en) Blood treatment filter
JP2005237791A (en) Method and system for filtering blood
WO2021006331A1 (en) Blood treatment filter
JP5749123B2 (en) Blood processing filter, blood processing system, and method for producing blood product
TW202206130A (en) Blood treatment filter which is excellent in all of leukocyte removal performance, filtration time and blood recovery
KR100704335B1 (en) Blood processing filter
JP2011235188A (en) Blood treatment filter

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090918

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110606

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110608

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110803

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110817

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120327

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120329

R150 Certificate of patent or registration of utility model

Ref document number: 4965212

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150406

Year of fee payment: 3

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees